Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 3 minute read Pharma Industry News REGENXBIO and Nippon Shinyaku collaborate on transformative gene therapies for MPS disorders In a significant move for the treatment of rare genetic diseases, REGENXBIO Inc. has entered an exclusive partnership… byPallavi MadhirajuJanuary 14, 2025